Biopharma/NIH 'PACT' Aims To Speed Cancer R&D
Executive Summary
A group of drug companies are collaborating with the National Institutes of Health and others in the Partnership for Accelerating Cancer Therapies in an effort to fund precompetitive cancer research, whose data will be shared broadly, with the aim of bringing more new therapies to patients in less time.